SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-098240
Filing Date
2023-12-22
Accepted
2023-12-22 16:30:29
Documents
91
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea190484-6k_aptorum.htm   iXBRL 6-K 20627
2 UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 AND DECE ea190484ex99-1_aptorum.htm   iXBRL EX-99.1 654032
3 OPERATING AND FINANCIAL REVIEW AND PROSPECTS IN CONNECTION WITH THE UNAUDITED IN ea190484ex99-2_aptorum.htm EX-99.2 89656
4 PRESS RELEASE ea190484ex99-3_aptorum.htm EX-99.3 72399
5 GRAPHIC ex99-3_001.jpg GRAPHIC 4535
  Complete submission text file 0001213900-23-098240.txt   5952909

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE apm-20230630.xsd EX-101.SCH 83189
7 XBRL CALCULATION FILE apm-20230630_cal.xml EX-101.CAL 50659
8 XBRL DEFINITION FILE apm-20230630_def.xml EX-101.DEF 325439
9 XBRL LABEL FILE apm-20230630_lab.xml EX-101.LAB 639895
10 XBRL PRESENTATION FILE apm-20230630_pre.xml EX-101.PRE 339748
85 EXTRACTED XBRL INSTANCE DOCUMENT ea190484-6k_aptorum_htm.xml XML 616703
Mailing Address 17 HANOVER SQUARE LONDON X0 W1S 1BN
Business Address 17 HANOVER SQUARE LONDON X0 W1S 1BN 852 3953 7700
Aptorum Group Ltd (Filer) CIK: 0001734005 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38764 | Film No.: 231510254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)